Isto Biologics News and Activities

Isto Biologics is owned by Thompson Street Capital Partners.

Thompson Street Capital Partners has 3 subsidiaries including Isto Biologics, Sabai and Vector Laboratories.

They are in:

• Biotechnology50%
• Financial Services25%
• Other25%

View the org chart displaying its 17 main executives

Most searched biographies at Isto Biologics

• Don Brown, Chief Executive Officer
• Bryan Choi, Chief Product Officer
• Lindsay Murphy, Vice President of Sales

Popular executive movements at Isto Biologics

• Jason Slade, Area Vice President of Sales, West, has left the company  (posted on June 29 2026).

Create your alert
to follow the executive moves at Isto Biologics.

Thompson Street Capital Partners has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• The new name of ChemoTech is Neem’s Hill. (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Isto Biologics

• What's New at Isto
• Isto Biologics
• Isto Biologics
• Isto Biologics

Social media about Isto Biologics

• Isto Biologics on Wikipedia, Google News & Yahoo Finance
• Isto Biologics on LinkedIn, X (Twitter) & YouTube